Home » Authors » Larry Haimovitch

Articles by Larry Haimovitch

Innovative devices offer hope for improved stroke therapy

Oct. 1, 2002

By Larry Haimovitch

Innovative devices offer hope for improved stroke therapy

Sep. 1, 2002

By Larry Haimovitch

OmniSonics, Quinton outline therapeutic, financial progress

Sep. 1, 2002

By Larry Haimovitch

'Golden age' brings more improvements in cataract surgery

July 1, 2002

By Larry Haimovitch

Role of new heart failure devices debated by electrophysiologist

June 1, 2002

By Larry Haimovitch

CHF impact on large patient pool spells opportunity for device firms

Aug. 1, 2001

By Larry Haimovitch

Mixed trial results fuel controversy over ICD-pacing device

July 1, 2001

By Larry Haimovitch

Controversy aside, sizable market opportunity exists in TMR, PTMR

July 1, 2001

By Larry Haimovitch

Temperature management moves to forefront as stroke treatment

June 1, 2001

By Larry Haimovitch

Coronary 're-dos' still a major frustration to interventionalists

Dec. 1, 2000

By Larry Haimovitch

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
Roche reports new TREM2 agonists
BioWorld Science
F. Hoffmann-la Roche Ltd. and Hoffmann-La Roche Inc. have identified new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for...